State Street Corp Amphastar Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 1,530,464 shares of AMPH stock, worth $62.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,530,464

Previous 1,529,536 0.06%

Holding current value

$62.5 Million

Previous $61.2 Million 21.4%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.99 - $50.09 $34,326 - $46,483	928 Added 0.06%	1,530,464 $74.3 Million
Q2 2024 Aug 14, 2024	BUY	$38.65 - $43.48 $590,842 - $664,678	15,287 Added 1.01%	1,529,536 $61.2 Million
Q1 2024 May 15, 2024	BUY	$42.85 - $63.45 $1.85 Million - $2.74 Million	43,112 Added 2.93%	1,514,249 $66.5 Million
Q4 2023 Feb 14, 2024	BUY	$44.49 - $62.93 $518,130 - $732,882	11,646 Added 0.8%	1,471,137 $91 Million
Q3 2023 Nov 14, 2023	BUY	$45.51 - $65.0 $2.96 Million - $4.22 Million	64,987 Added 4.66%	1,459,491 $67.1 Million
Q2 2023 Aug 14, 2023	BUY	$35.77 - $58.38 $1.25 Million - $2.04 Million	35,009 Added 2.58%	1,394,504 $80.1 Million
Q1 2023 May 15, 2023	BUY	$27.99 - $37.92 $27,570 - $37,351	985 Added 0.07%	1,359,495 $51 Million
Q4 2022 Feb 14, 2023	SELL	$27.93 - $31.27 $4.9 Million - $5.48 Million	-175,283 Reduced 11.43%	1,358,510 $38.1 Million
Q3 2022 Nov 15, 2022	SELL	$27.56 - $37.75 $194,380 - $266,250	-7,053 Reduced 0.46%	1,533,793 $43.1 Million
Q2 2022 Aug 15, 2022	BUY	$29.79 - $42.29 $6.52 Million - $9.26 Million	218,895 Added 16.56%	1,540,846 $53.6 Million
Q1 2022 May 16, 2022	SELL	$22.96 - $36.45 $2.69 Million - $4.27 Million	-117,256 Reduced 8.15%	1,321,951 $47.5 Million
Q4 2021 Feb 14, 2022	SELL	$18.14 - $23.29 $383,261 - $492,071	-21,128 Reduced 1.45%	1,439,207 $33.5 Million
Q3 2021 Nov 15, 2021	BUY	$17.83 - $21.49 $363,803 - $438,481	20,404 Added 1.42%	1,460,335 $27.8 Million
Q2 2021 Aug 16, 2021	BUY	$17.11 - $20.92 $598,473 - $731,739	34,978 Added 2.49%	1,439,931 $29 Million
Q1 2021 May 17, 2021	BUY	$17.21 - $20.65 $2.1 Million - $2.51 Million	121,789 Added 9.49%	1,404,953 $25.7 Million
Q4 2020 Feb 16, 2021	SELL	$17.76 - $21.24 $130,109 - $155,604	-7,326 Reduced 0.57%	1,283,164 $25.8 Million
Q3 2020 Nov 10, 2020	BUY	$17.99 - $22.22 $544,593 - $672,643	30,272 Added 2.4%	1,290,490 $24.2 Million
Q2 2020 Aug 14, 2020	BUY	$14.25 - $22.46 $896,681 - $1.41 Million	62,925 Added 5.26%	1,260,218 $28.3 Million
Q1 2020 May 11, 2020	BUY	$12.66 - $20.08 $15.2 Million - $24 Million	1,197,293 New	1,197,293 $17.8 Million

Others Institutions Holding AMPH

# of Institutions

287

Shares Held

35.1M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Amphastar Pharmaceuticals, Inc. Transaction History